Table III.
Total stress | Test |
Control |
Difference test-control | 95% CI | ||||
---|---|---|---|---|---|---|---|---|
n | Mean | SD | n | Mean | SD | |||
T1—Baseline | 114 | 14.99 | 4.58 | 93 | 14.80 | 5.10 | 0.19 | −1.15 to 1.54 |
T2—Cycle 1, Day 6 | 81 | 16.11 | 4.92 | 63 | 16.73 | 6.04 | −0.62 | −2.47 to 1.24 |
T3—Cycle 1, Surge Day | 73 | 16.79 | 4.86 | 61 | 16.26 | 6.08 | 0.53 | −1.38 to 2.44 |
T4—Cycle 2, Day 6 | 52 | 17.29 | 6.00 | 51 | 16.10 | 5.49 | 1.19 | −1.06 to 3.44 |
T5—Cycle 2, Surge Day | 48 | 17.25 | 5.43 | 47 | 15.23 | 5.38 | 2.02 | −0.19 to 4.22 |
T6—Cycle 3 | 37 | 17.76 | 6.48 | 40 | 15.78 | 6.25 | 1.98 | −0.91 to 4.87 |
Negative affect | ||||||||
T1—Baseline | 113 | 14.16 | 4.03 | 93 | 14.37 | 4.58 | −0.21 | −1.41 to 0.99 |
T2—Cycle 1, Day 6 | 82 | 16.29 | 5.76 | 62 | 16.84 | 6.64 | −0.55 | 1.06 to −2.64 |
T3—Cycle 1, Surge Day | 73 | 15.85 | 5.02 | 62 | 15.39 | 5.02 | 0.46 | 0.87 to −1.25 |
T4—Cycle 2, Day 6 | 51 | 18.37 | 6.17 | 50 | 17.44 | 6.16 | 0.93 | 1.23 to −1.50 |
T5—Cycle 2, Surge Day | 47 | 16.62 | 6.21 | 47 | 16.28 | 6.60 | 0.34 | 1.32 to −2.28 |
T6—Cycle 3 | 38 | 17.55 | 6.97 | 40 | 16.90 | 6.64 | 0.65 | 1.54 to −2.42 |
Positive affect | ||||||||
T1—Baseline | 114 | 36.14 | 7.00 | 92 | 37.96 | 6.26 | −1.82 | −3.64 to 0.01 |
T2—Cycle 1, Day 6 | 82 | 32.52 | 7.06 | 62 | 32.16 | 8.72 | 0.36 | −2.32 to 3.05 |
T3—Cycle 1, Surge Day | 72 | 32.58 | 8.06 | 62 | 34.63 | 7.55 | −2.05 | −4.72 to 0.62 |
T4—Cycle 2, Day 6 | 50 | 31.16 | 8.71 | 50 | 33.04 | 8.16 | −1.88 | −5.22 to 1.47 |
T5—Cycle 2, Surge Day | 47 | 31.55 | 8.50 | 47 | 34.28 | 7.78 | −2.73 | −6.06 to 0.61 |
T6—Cycle 3 | 36 | 29.75 | 10.24 | 38 | 34.26 | 8.06 | −4.51 | −8.80 to −0.22 |
SF-12 | ||||||||
Physical T1—Baseline | 115 | 39.80 | 3.53 | 93 | 39.65 | 3.28 | 0.15 | −0.78 to 1.10 |
Physical T6—Cycle 3, Day 6 | 38 | 41.86 | 4.00 | 40 | 41.12 | 3.14 | 0.74 | −0.87 to 2.37 |
Mental T1—Baseline | 115 | 49.57 | 3.89 | 93 | 48.42 | 4.50 | 1.15 | 0.01 to 2.31 |
Mental T6—Cycle 3, Day 6 | 38 | 46.40 | 7.15 | 40 | 46.15 | 5.11 | 0.25 | −2.54 to 3.04 |
Cortisol (µg/dl):Creatinine (g/dl) | ||||||||
T2—Cycle 1, Day 6 | 84 | 136.29 | 62.82 | 66 | 157.23 | 138.92 | −20.94 | −57.35 to 15.46 |
T3—Cycle 1, Surge Day | 69 | 129.15 | 70.36 | 61 | 149.04 | 85.20 | −19.89 | −47.22 to 7.44 |
T4—Cycle 2, Day 6 | 51 | 147.68 | 110.30 | 44 | 147.57 | 89.59 | 0.11 | −40.63 to 40.85 |
T5—Cycle 2, Surge Day | 47 | 127.75 | 65.42 | 45 | 149.16 | 92.40 | −21.41 | −54.70 to 11.88 |
T6—Cycle 3 | 37 | 139.33 | 59.03 | 38 | 156.23 | 89.44 | −16.9 | −51.69 to 17.89 |
E3G (ng/ml):Creatinine (g/dl) | ||||||||
T2—Cycle 1, Day 6 | 84 | 98.99 | 56.69 | 66 | 101.34 | 46.23 | −2.35 | −18.94 to 14.26 |
T3—Cycle 1, Surge Day | 69 | 403.15 | 237.43 | 61 | 276.31 | 180.57 | 126.84 | 54.10 to 199.58 |
T4—Cycle 2, Day 6 | 51 | 104.90 | 79.52 | 44 | 108.32 | 56.13 | −3.42 | −31.19 to 24.35 |
T5—Cycle 2, Surge Day | 47 | 311.11 | 206.71 | 45 | 261.54 | 182.65 | 49.57 | −31.14 to 130.28 |
T6—Cycle 3 | 37 | 101.59 | 52.34 | 38 | 95.24 | 52.43 | 6.35 | −17.76 to 30.46 |
The number of evaluable data points may not match those in Fig. 1 because of missing or incomplete questionnaires at specific time points.
(E3G, estrone-3-glucuronide).